Hit enter to search or ESC to close
YOZMA GROUP KOREAYOZMA GROUP KOREA
Menu
  • About
    • Overview
    • Yozma Story
    • Team
  • Business
    • Investment
    • Business Development
    • Tech Transfer
  • Portfolio
  • Newsroom
    • News
    • Video
  • Contact
  • English
    • Korean
  • About
    • Overview
    • Yozma Story
    • Team
  • Business
    • Investment
    • Business Development
    • Tech Transfer
  • Portfolio
  • Newsroom
    • News
    • Video
  • Contact
  • English
    • Korean
Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
Press Release

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

By yozmakorea2023-08-17August 22nd, 2023No Comments

Home » Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT

https://www.globenewswire.com/en/news-release/2023/08/17/2727669/0/en/Alpha-Tau-Announces-Robust-Long-Term-Safety-and-Efficacy-Data-from-Multiple-Clinical-Trials-of-Alpha-DaRT.html

Tags:

AlphaTau알파타우
  • Previous Post"Cyberattacks capable of manipulating the public opinion could shake the foundation of democracy"

  • Next Post[Interview] Asaf Ashkenazi Everysight CEO

서울 오피스 / Seoul Office
서울시 강남구 봉은사로 457 S&C TOWER 9층
9F, S&C TOWER, 457, Bongeunsa-ro, Gangnam-gu, Seoul, Republic of Korea
t. +82 2 6949 5350
e. [email protected]

Israel Office
2 Ben Gurion way, BSR 1 building fl 14, Ramat Gan, Israel
e. [email protected]

Family Site
Yozma Group Israel HQ
Yozma Campus (PR/Marketing)

  • Privacy Policy

© 2026 Yozma Group Korea.